INDUSTRY PROFILE
Gene therapy delivers genetic fixes for inherited and acquired diseases using viral vectors and genome editing. It recruits molecular biologists and bioengineers from academia and frequently licenses university-developed editing and delivery technologies.
MARKET SIZE
$95B
KEY COMPANIES
10
TARGET RESEARCHERS
Molecular biologists and bioengineers in viral vectors, genome editing, delivery, and translational medicine
KEY COMPANIES
Spark Therapeutics
Sarepta Therapeutics
BioMarin
uniQure
Sangamo Therapeutics
Intellia Therapeutics
Beam Therapeutics
Editas Medicine
Krystal Biotech
Solid Biosciences
USE CASES
AAV vector-engineering R&D hiring
CRISPR delivery partnerships
University gene-therapy-lab spin-outs
GMP and translational talent pipeline
Rare-disease research collaborations
TRY IT
Install the CLI and run your first search in under a minute. No account required to explore.
npx sci-buy@latest COPIED